Circulating endothelial cells and their progenitors in acute myeloid leukemia.
Acute myeloid leukemia (AML) is an aggressive hematological malignancy characterized by the accumulation of immature myeloid progenitor cells in the bone marrow. Studies are required to investigate the prognostic and predictive value of surrogate biomarkers. Given the importance of angiogenesis in oncology in terms of pathogenesis as well as being a target for treatment, circulating endothelial cells (CECs) and endothelial progenitor cells (EPCs) are promising candidates to serve as such markers. The aim of the present study was to quantify CECs and EPCs in patients with AML at initial diagnosis and following induction chemotherapy, and to correlate these findings with the response to treatment in AML patients. The present study included 40 patients withde novoAML and 20 age- and gender-matched healthy controls. CECs and EPCs were evaluated by flow cytometry at initial diagnosis and after induction chemotherapy (3+7 protocol for AML other than M3 and all-trans-retinoic acid plus anthracycline for M3 disease). CECs and EPCs were significantly higher in AML patients at diagnosis and after induction chemotherapy than in controls. After induction chemotherapy, CECs and EPCs were significantly decreased compared with the levels at initial diagnosis. Patients who achieved complete response (n=28) had lower initial CEC and EPC levels compared with patients who did not respond to treatment. These results suggest that CEC levels are higher in AML patients and may correlate with disease status and treatment response. Further investigations are required to better determine the predictive value and implication of these cells in AML management.
Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut 71111, Egypt.
Asmaa Mohammed
AM
Zahran
Department of Clinical Pathology, Faculty of Medicine, South Valley University, Qena 83523, Egypt.
Sanaa Shaker
SS
Aly
Department of Medical Oncology, South Egypt Cancer Institute, Assiut University, Assiut 71111, Egypt.
Hanan Ahmed
HA
Altayeb
Department of Medical Oncology, South Egypt Cancer Institute, Assiut University, Assiut 71111, Egypt.
Arwa Mohammed
AM
Ali
acute myeloid leukemia; circulating endothelial cells; prognostic biomarkers